Article
Pharmacogenetic Optimization of Smoking Cessation Treatment.
Trends in pharmacological sciences - 1 Jan 2017
Chenoweth Meghan J, Tyndale Rachel F
Abstract excerpt
Worldwide, approximately one billion people smoke cigarettes. Cigarette smoking persists in part because long-term smoking cessation rates are modest on existing treatments. Smoking cessation outcomes are influenced by genetic factors, including genetic variation in enzymes that metabolize nicotine and smoking cessation medications, as well as in receptor targets for nicotine and treatment medications. For...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
